Skip to main content
. 2017 Jul 18;15:53. doi: 10.1186/s12958-017-0272-3

Fig. 1.

Fig. 1

Therapeutic effects of arcyriaflavin A on endometriotic cyst stromal cells (ECSCs). a Cell viability; b 5-bromo-2-deoxyuridine (BrdU) incorporation; c vascular endothelial growth factor (VEGF)-A protein level; d apoptotic activity; e caspase-3/7 activity; f cell cycle progression. ae ECSCs were analyzed following 48-h incubation with arcyriaflavin A. f ECSCs were analyzed using flow cytometry following a 72-h incubation with arcyriaflavin A. *p < 0.05 and **p < 0.005, Bonferroni method